Immune Plasma: A Promising Therapy to Treat Influenza
![]()
June 7, 2017
Many observational and case studies have suggested that convalescent plasma may have a therapeutic role in the treatment of influenza and other infectious diseases. Recently, researchers from 29 U.S. medical centers performed the first clinical trial to test the safety and efficacy of immune plasma (plasma collected from individuals with high antibody titers to influenza) [Read More]
Many observational and case studies have suggested that convalescent plasma may have a therapeutic role in the treatment of influenza and other infectious diseases. Recently, researchers from 29 U.S. medical centers performed the first clinical trial to test the safety and efficacy of immune plasma (plasma collected from individuals with high antibody titers to influenza) [Read More]
Feasibility of Post-donation Iron Replacement for Whole Blood Donors
Female blood donors and young donors have a particularly high risk for iron deficiency, and randomized trials have shown that iron replacement is important for recurrent donors. In order to assess the feasibility of iron-replacement for donors, researchers in Australia recruited female blood donors (18-45 years old) into two parallel replacement programs. Just over 1400 [Read More]
High-Throughput Sequencing Used To Identify Pathogens in Donated Blood
Ensuring a safe blood supply requires multiple strategies and is continually evolving with new, emerging pathogens. Researchers in Switzerland recently used high-throughput sequencing to screen 300 units of donated red blood cell and 300 units of donated plasma products. Sequences obtained were then blasted against virus, bacteria and fungi databases
No comments:
Post a Comment